Abstract: Oculoectodermal syndrome is a rare disease characterized by the association of aplasia cutis congenita, epibulbar dermoids, and other abnormalities. This report describes the twentieth case of the disease. We report a 4-year-old female child who presented with the classical features of the syndrome: aplasia cutis congenita and epibulbar dermoids. Our case expands the clinical spectrum of the disease to include: diffuse hyperpigmentation (some following the Blaschko´s lines); hypopigmented skin areas on the trunk; arachnoid cyst on the right fronto-parietal border; rounded left side of the hippocampus; and dermoid cyst underlying the bulb-medullary transition. Our patient also reported infantile hemangioma on the right wrist and verrucous hemangioma on the left leg, the latter not previously described in the literature.
INTRODUCTION
Oculoectodermal syndrome was first reported in 1993 by
Toriello et al. Characteristic clinical signs of the syndrome include aplasia cutis congenita and epibulbar dermoids. 1 Other abnormalities involving the central nervous system, bones, urogenital system and vascular system were also observed. Fifteen cases reviewed by Ardinger et al. included giant cell granuloma of the jaw, nonossifying fibroma, cutaneous hyperpigmentation, arachnoid cyst, coarctation of the aorta, and rhabdomyosarcoma. 2 Studies also report the presence of epidermal nevi following the lines of Blaschko, hypopigmented lesions, and digital anomalies. Oculoectodermal syndrome can be considered a milder variation of encephalocraniocutaneous lipomatosis, differing primarily in the absence of cranial defects. The genetic cause of the disease is unknown and all cases reported were sporadic. Currently, the only detected molecular pathology has been a deletion on Xq12, but its status as a disease-causing aberration remains unclear. 4 We report a newly diagnosed case with a broad clinical spectrum, with some comorbidities that were described for the first time.
CASE REPORT
The patient was seen for the first time when she was four. Despite the changes described in the cranial MRI, our patient had intellectual development consistent with her age, in contrast to some reports of attention deficit disorder, speech disturbances, and developmental disorders described in OES. 5 Currently, the underlying molecular defect in OES is unknown and all reported cases have been sporadic. Although a new mosaic deletion at Xq12 was recently defined, it is unclear whether this genetic abnormality is pathogenic. Hypotheses suggested for its etiology include autosomal recessive inheritance, tumor suppressor gene mutation, genetic defect in transcription factor that controls eye development, de novo mutation, and mosaicism. [6] [7] [8] [9] Authors suggest that OES is a mild variant of CCLE, a neurocutaneous syndrome that differs primarily by the lack of intracranial lipomas. According to the criteria revised by Moog, our patient seems to have OES, since no intracranial lipoma was observed.
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Although skin and eye findings are both relatively innocuous, other systemic diseases -such as seizures, psychomotor retardation, vaso-occlusive crisis, cardiac malformations, and various birth defects -should be considered. We emphasize the importance of seeking a definitive diagnosis when faced with a multisystem di- 
